Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review
Open Access
- 1 May 2016
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 69 (5) , 802-820
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effects of Serum Testosterone Levels After 6 Months of Androgen Deprivation Therapy on the Outcome of Patients With Prostate CancerClinical Genitourinary Cancer, 2013
- Intermittent Androgen Suppression for Rising PSA Level after RadiotherapyNew England Journal of Medicine, 2012
- Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate CancerJournal of Clinical Oncology, 2012
- Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective StudyCancer Research and Treatment, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Prostate-specific antigen doubling time predicts the development of distant metastases for patients who fail 3-dimensional conformal radiotherapy or intensity modulated radiation therapy using the Phoenix definitionPractical Radiation Oncology, 2011
- The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen DeprivationThe Prostate, 2011
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular RiskCirculation, 2010
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical ProstatectomyJAMA, 2008
- Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapyCancer, 2003